Regulation of Mitochondrial Fission and Fusion
线粒体裂变和融合的调节
基本信息
- 批准号:7969639
- 负责人:
- 金额:$ 35.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AmericanApoptosisAreaAutosomal Dominant Optic AtrophyBrainCell physiologyCellsCellular biologyCharcot-Marie-Tooth DiseaseCyclic AMPDevelopmentDiseaseDominant-Negative MutationDynaminDystoniaEquilibriumEventFunctional disorderGenesGuanosine Triphosphate PhosphohydrolasesHereditary Spastic ParaplegiaInheritedIntegral Membrane ProteinInvestigationLaboratoriesMammalsMitochondriaMitochondrial DiseasesModificationMolecularMorphologyMutateMutationNeurodegenerative DisordersNeurologyOptic AtrophyOrganellesPatientsPhosphorylationProcessProteinsPublishingRegulationResearchRoleSiteSyndromeclinically relevanthuman OPA1 proteininsightlactic acidemianervous system disordernew therapeutic target
项目摘要
Research in the Cellular Neurology Unit focuses on the molecular mechanisms underlying a number of neurodegenerative disorders, including mitochondrial disorders, dystonia, and the hereditary spastic paraplegias (HSPs). These disorders, which together afflict millions of Americans, worsen insidiously over a number of years, and treatment options are limited for many of them. Our laboratory is investigating inherited forms of these disorders, using molecular and cell biology approaches to study how mutations in disease genes ultimately result in cellular dysfunction.
In this project, we are emphasizing investigations into the regulation of mitochondrial morphology within cells. Indeed, fusion and fission events that regulate mitochondrial morphology are essential for proper mitochondrial function, and their regulation is increasingly recognized in diverse cellular functions. Mitochondrial fission events in mammals are orchestrated by at least two proteins; the dynamin-related protein Drp1 and the integral membrane protein Fis1. The reciprocal process of mitochondrial fusion also requires large GTPases of the dynamin superfamily: OPA1 and the mitofusins Mfn1 and Mfn2. Since mutations in Drp1, Mfn2, and OPA1 have been identified in patients with inherited neurological disorders, and there is prominent fragmentation of mitochondria during programmed cell death, insights into the regulation of these processes is highly relevant clinically.
In 2007, we published a study demonstrating that cAMP-dependent protein phosphorylation of the Drp1 protein modulates its GTPase activity as well as mitochondrial morphology. We now have collaborative investigations underway focusing on the relevance of this modification in the regulation of a number of intracellular processes, including one study that was published in 2008. In addition, we have identified the sites of sumoylation within the Drp1 protein and are currently using dominant-negative approaches to determine the functional role of sumoylation in Drp1 function. We have recently completed a study of the Drp1 A395D mutation that caused a neonatally fatal mitochondrial disorder due to markedly diminished mitochondrial fission. In this study, we were able to show that this mutation resulted in loss of higher-order multimeric interactions of the Drp1 protein. Lastly, in ongoing studies we have identified a number of Drp1-interacting proteins that may be involved in the proper distribution of mitochondria within cells.
Together, these studies are continuing to provide critical insights into the regulation of mitochondrial morphology within a cell, an area of increasing clinical relevance and importance.
细胞神经学单元的研究重点是一些神经退行性疾病的分子机制,包括线粒体疾病,肌张力障碍和遗传性痉挛性截瘫(HSP)。 这些疾病共同折磨着数百万美国人,在数年内不知不觉地恶化,其中许多人的治疗选择有限。 我们的实验室正在研究这些疾病的遗传形式,使用分子和细胞生物学方法来研究疾病基因的突变如何最终导致细胞功能障碍。
在这个项目中,我们强调研究细胞内线粒体形态的调节。事实上,调节线粒体形态的融合和裂变事件对于适当的线粒体功能是必不可少的,并且它们的调节在多种细胞功能中越来越多地被认识到。 哺乳动物的线粒体分裂事件由至少两种蛋白质协调:动力蛋白相关蛋白Drp1和膜整合蛋白Fis1。 线粒体融合的相互过程也需要发动蛋白超家族的大GTP酶:OPA1和线粒体融合蛋白Mfn1和Mfn2。 由于在遗传性神经系统疾病患者中发现了Drp1、Mfn2和OPA1的突变,并且在程序性细胞死亡过程中存在线粒体的显著片段化,因此对这些过程的调控的了解在临床上具有高度相关性。
2007年,我们发表了一项研究,证明Drp1蛋白的cAMP依赖性蛋白磷酸化调节其GTdR活性以及线粒体形态。 我们现在正在进行合作研究,重点是这种修饰在调节许多细胞内过程中的相关性,包括2008年发表的一项研究。此外,我们已经确定了Drp1蛋白内的SUMO化位点,目前正在使用显性负性方法来确定SUMO化在Drp1功能中的功能作用。 我们最近完成了一项关于Drp1 A395D突变的研究,该突变由于线粒体分裂明显减少而导致了致命的线粒体疾病。 在这项研究中,我们能够证明这种突变导致Drp1蛋白的高阶多聚体相互作用的丧失。最后,在正在进行的研究中,我们已经确定了一些Drp1相互作用的蛋白质,这些蛋白质可能参与细胞内线粒体的正确分布。
总之,这些研究继续为细胞内线粒体形态的调节提供重要见解,这是一个临床相关性和重要性日益增加的领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Craig Blackstone其他文献
Craig Blackstone的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Craig Blackstone', 18)}}的其他基金
ER Network Shaping Mechanisms in the Hereditary Spastic Paraplegias
遗传性痉挛性截瘫的 ER 网络塑造机制
- 批准号:
9563114 - 财政年份:
- 资助金额:
$ 35.78万 - 项目类别:
ER Network Shaping Mechanisms in the Hereditary Spastic Paraplegias
遗传性痉挛性截瘫的 ER 网络塑造机制
- 批准号:
9358549 - 财政年份:
- 资助金额:
$ 35.78万 - 项目类别:
ER Network Shaping Mechanisms in the Hereditary Spastic Paraplegias
遗传性痉挛性截瘫的 ER 网络塑造机制
- 批准号:
8557028 - 财政年份:
- 资助金额:
$ 35.78万 - 项目类别:
ER Network Shaping Mechanisms in the Hereditary Spastic Paraplegias
遗传性痉挛性截瘫的 ER 网络塑造机制
- 批准号:
8940058 - 财政年份:
- 资助金额:
$ 35.78万 - 项目类别:
ER Network Shaping Mechanisms in the Hereditary Spastic Paraplegias
遗传性痉挛性截瘫的 ER 网络塑造机制
- 批准号:
9157507 - 财政年份:
- 资助金额:
$ 35.78万 - 项目类别:
ER Network Shaping Mechanisms in the Hereditary Spastic Paraplegias
遗传性痉挛性截瘫的 ER 网络塑造机制
- 批准号:
8746791 - 财政年份:
- 资助金额:
$ 35.78万 - 项目类别:
Endocytic Mechanisms in the Hereditary Spastic Paraplegias
遗传性痉挛性截瘫的内吞机制
- 批准号:
8746852 - 财政年份:
- 资助金额:
$ 35.78万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 35.78万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 35.78万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 35.78万 - 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 35.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 35.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 35.78万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 35.78万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 35.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 35.78万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 35.78万 - 项目类别:
Discovery Grants Program - Individual